Testing Home Fetal Heart Monitoring for High-Risk Pregnancies
Tests a home device that checks baby's heart rate in high-risk pregnancies.
Key facts
- Who runs it
- Beth Israel Deaconess Medical Center
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Remote Fetal Monitoring in High Risk Pregnancies
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 1 May 2025
- Expected to end
- 1 Jan 2027
- Type of study
- Observational
- Treatments tested
- Fetal ECG monitoring
- Record updated
- 9 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women past 32 weeks with a high risk pregnancy who are asked by their obstetrician to have fetal testing at least once a week. They test fetal monitoring at home.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- High risk pregnancy, more than 32 weeks of pregnancy
Main reasons for not taking part
- Under 18 years old
- Does not speak English
This trial only enrols pregnant participants. The registry sentence this rests on: Intrauterine pregnancy greater than 32 weeks gestation
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Intrauterine pregnancy greater than 32 weeks gestation
- Recommended for at least once weekly antenatal fetal testing by their obstetrician
- English-speaking
Who cannot take part
- Under age 18 years of old
- Non-english speaking
Where in United States
- Beth Israel Deaconess Medical CenterBoston, United StatesContact: Ethan Litman, MD,MSTaking people
About the trial
What the trial wants to find out
Antenatal nonstress tests (NSTs) are performed to assess fetal health and are used as a cost-effective test that can be widely administered. However, an NST is operator-dependent due to the nature of Doppler ultrasound and is primarily performed in a clinic and hospital setting.
Read full original descriptionShow less
The ability to conduct a clinically valuable test at home would address access to care issues faced by numerous women in the United States and reduce the workload on healthcare clinicians facing a shortage of human resources.
This pilot study aims to assess the feasibility and acceptability of home NST monitoring in order to determine whether femomTM could be utilized as an adjunct to routine prenatal care.
Patients with high risk pregnancies who are recommended to undergo at least once weekly at 32 weeks testing by the obstetrician will be recruited for participation in this study. Participants will be asked to perform three 30 minute monitoring sessions weekly starting at 32 weeks for 6 weeks.
The group in the trial
- Remote Monitoring
A cohort of patients with high risk pregnancies who will wear a remote monitoring device
Treatment: Fetal ECG monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating the Acceptability and Feasibility of Remote Fetal Monitoring in a High Risk Obstetric Population
- Plain-language title
- Testing Home Fetal Heart Monitoring for High-Risk PregnanciesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 March 2026